EFFECTOR to Work with Pfizer and Merck on Evaluating Colorectal Cancer Immunotherapy Combo
News
EFFECTOR Therapeutics will team up with Pfizer and Merck’s operation in Darmstadt, Germany, to evaluate an immuno-oncology combination theapy in patients with microsatellite stable colorectal cancer. Set to begin in the third quarter of 2017, ... Read more